Allianz Asset Management
ACET icon

Allianz Asset Management’s Adicet Bio ACET Stock Holding History

Allianz Asset Management’s Portfolio ACET Stock Details ACET Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-2,094
Closed -$476K – 1971
2022
Q3 		$476K Sell
2,094
-6,599
-76% -$1.67M ﹤0.01% 1546
2022
Q2 		$3.16M Buy
8,693
+4,992
+135% +$1.1M ﹤0.01% 1253
2022
Q1 		$1.18M Buy
3,701
+1,271
+52% +$292K ﹤0.01% 1779
2021
Q4 		$680K Buy
+2,430
New +$417K ﹤0.01% 2077

Other funds holding ACET

O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
CAC
Cowen and Company New York $2.97B AUM 105.26% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
A
Abingworth London, United Kingdom $307M AUM 93.47% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
PCH
Polar Capital Holdings London, United Kingdom $28.2B AUM 115.26% 1-Year Est. Return

Allianz Asset Management's ACET Position: Q4 2022 in Review

Allianz Asset Management sold out of Adicet Bio (ACET) in Q4 2022, closing a stake of 2,094 shares — an estimated $476K sold.

Allianz Asset Management first reported a position in ACET in Q4 2021 and held it in 4 quarters. The position peaked at $3.16M in Q2 2022. 100 funds tracked by Wall St. Rank hold ACET as of Q4 2022.

  • Allianz Asset Management reported no remaining Adicet Bio position as of Q4 2022 after selling out during the quarter.
  • Allianz Asset Management sold 2,094 Adicet Bio shares in Q4 2022, an estimated $476K.
  • Allianz Asset Management first reported a position in Adicet Bio in Q4 2021 and held it in 4 quarters.
  • Allianz Asset Management's Adicet Bio position peaked at $3.16M in Q2 2022.
  • 100 funds tracked by Wall St. Rank held Adicet Bio as of Q4 2022.

Based on Allianz Asset Management's 13F filing for Q4 2022, filed 13 Feb 2023.